RIG-I Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of RIG-I monoclonal antibodies for the detection and analysis of RIG-I protein, a key player in the innate immune response. RIG-I monoclonal antibodies are compatible with multiple research techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). RIG-I, or Retinoic acid-inducible gene I, is crucial for recognizing viral RNA and initiating antiviral responses, making it essential for understanding host-pathogen interactions. RIG-I plays a significant role in immune system regulation and viral defense mechanisms. Understanding RIG-I function contributes to the development of therapeutic strategies against viral infections. RIG-I research advances knowledge in autoimmune disease mechanisms and potential treatments. Investigating RIG-I helps reveal critical aspects of immune signaling pathways and their implications in health and disease. Santa Cruz Biotechnology monoclonal antibodies for RIG-I support researchers worldwide in advancing scientific understanding of immune system responses and viral defense mechanisms.